Matthew Cheng, MD

Assistant Professor
McGill University Health Centre
Montreal, Quebec, Canada

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 733 - Letermovir treatment for refractory or resistant cytomegalovirus infection or disease with concurrent organ dysfunction: an interim analysis of a Phase 2 open label study.

  Thursday, October 20, 2022
  2:30 PM – 2:45 PM US ET